Health Care

President Trump's Drug Costs Proposals Coming Soon

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

FDA Study on BPA: Nothing's Changed Since February

You may recall a March 5, WasteWatcher blog, “New FDA Report on BPA: It is Still Safe,” which discussed a pre-peer review draft study released by the National Toxicology Program (NTP) on bisphenol A (BPA), a compound used to produce plastic products and epoxy resins used in food and beverage can linings.  The study, two-years in length and the largest ever conducted on BPA, took place at the Food and Drug Administration’s (FDA) National Center for Toxicological Research (NCTR).

Citizens Against Government Waste Highlights GAO Duplication Report

(Washington, D.C.) – Citizens Against Government Waste (CAGW) highlighted the release of the Government Accountability Office’s (GAO) eighth annual report on, “Additional Opportunities to Reduce Fragmentation, Overlap, and Duplication and Achieve Other Financial Benefits.”

The Fourth Circuit Was Right to Reject Price Controls for Generic Drugs

This prudent decision will send a strong message to other state legislatures across the country not to pursue similar legislation.

Obamacare is Bringing BIG Changes

The Patient Protection and Affordable Care Act, or Obamacare, is bringing many changes in the healthcare space and few are as subtly transformative as the rapid increase in cross-industry consolidation.  A record breaking 115 mergers and acquisitions among hospitals and health systems occurred in 2017, an increase of 13 percent from 2016.

Stealing Patents Won’t Bring Down Drug Costs

On February 15, 2018, 18 Democratic members of Congress sent a letter to Health and Human Services (HHS) Secretary Alex Azar, asking him to use his authority under 28 U.S.C.

A Moment of Truth: Will Virginia Republicans Expand Medicaid?

On April 11, 2018, Virginia legislators will return to Richmond for a special session in which they will aim to finish work on the Commonwealth’s budget.  At center stage, yet again, is the issue of Medicaid expansion, still unresolved eight years after Obamacare became law.

Comments to FDA on Modified Risk Tobacco Product Applications

March 21, 2018

Commissioner Scott Gottlieb, M.D.
Food and Drug Administration
Dockets Management Staff
HFA-305
5630 Fishers Lane
Room 1061
Rockville, Maryland  20852

Attention

Docket Number FDA-2017-D-3001
Modified Risk Tobacco Product Applications (MRTPA) by Philip Morris Products S.A. Applications for IQOS system with Marlboro Heatsticks, IQOS system with Marlboro Smooth Menthol Heatsticks, and IQOS system with Marlboro Fresh Menthol Heatsticks

Council for Citizens Against Government Waste Releases 2017 Congressional Ratings

(Washington, D.C.) – The Council for Citizens Against Government Waste (CCAGW) today released its 2017 Congressional Ratings, highlighting the voting records of all 535 voting members of Congress during the first session of the 115th Congress.  The report, which CCAGW has issued since 1989, identifies members whose voting records helped protect taxpayer dollars, as well as those who consistently voted against their interests.

Any Willing Pharmacy – Not as Good as it Sounds

On November 28, 2017, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule that would revise Medicare Part D, the prescription drug program.  The proposal dredges up the “any willing pharmacy” issue that would require any Part D plan sponsor, such as an insurer or a pharmacy benefit manager (PBM), to allow any pharmacy to participate in their network.  While this policy has a benign name, if it is adopted, it will drive up costs for all Medicare beneficiaries, not lower them.

Pages

Sign Up for Email Updates!Click Here!

CAGW Names Rep. Mike Rogers November 2018 Porker of the Month

Rep. Hoyer is CAGW's Porker of the Month for his support for being a leading proponent of a wasteful sixth military branch called the Space Force.